SGO Journal Club On-Demand: Advanced Endometrial Cancer—the Next Generation of Treatment
The case: 53yo S/P hysterectomy/BSO/SLND for FIGO grade3 endometrial cancer with extensive LVSI and no myometrial invasion. Further imaging identifies lung nodules biopsied positive for endometrioid adenocarcinoma.
Questions to consider:
1. What molecular testing should be performed by Pathology on this case?
2. What treatment strategy should we take?
Reference Links:
PMID: 37337978
PMID: 29432521
PMID: 36972022
PMID: 36972026
PMID: 37864337
SGO Communique - Newly approved and investigational therapies for endometrial cancer
Panelists:
Dana Chase, MD, FACOG
Associate Professor, Obstetrics & Gynecology, UCLA
Tony Karnezis, MD, PhD
Associate Professor, Department of Pathology
UC Davis Medical Center
Todd Tillmanns, MD, FACOG
Gynecologic Oncologist, West Cancer Center & Research Institute
Moderators:
Lee-may Chen, MD
Gynecologic Oncologist and Gynecologic Oncology Division Director, UCSF
Renata Urban, MD
Gynecologic Oncologist, UW Medical
Keywords: journal, journal club, endometrial, endometrial cancer, advanced endometrial cancer